New German Health Minister Takes Aim At Traditional Pharma Companies.
Newly appointed German Healthcare Minister Philipp Roesler – liberal – Free Democratic Party in likely move to break big pharma stronghold and submit new products to insurance pricing scrutiny and impose an “efficiency and clinical effectiveness /outcomes” pricing performance ratio.
Not totally dissimilar to the British NICE economic and clinical effectiveness system.
Sign of the times perhaps to introduce new effectiveness and economic liberalization in the DME (durable medical equipment) sector of the ever increasing homecare industry.
Maybe not – Roesler is clearly risking his parties popularity as a junior member in Chancellor Angela Merkel’s Christian Democrat Party.
About Frank Barlin
Frank is the founder and managing partner at Sibaya. He provides recognized leadership in homecare consulting and has advised firms ranging in size from those listed on the NYSE and the LSE to early stage startups.
Frank’s international experience is broad-based, having spent his professional life based in Europe, the United States and South Africa. Prior to founding Sibaya in 2002 he was European Vice President for a publicly traded healthcare company.
In addition he has held various country general management positions and directorships. Recent home healthcare projects include European business development, acquisition strategy and advice, competitive benchmarking, Asian outsourcing and turnaround management. He works out of the Paris office.
Trackbacks/Pingbacks
[...] Previous post German Health Minister Philipp Roesler – To Slam Pharma – (Wheelchairs And Homecare Next)? [...]